Vimarsana
Biggest News Aggregation in the World

Page 10 - Aldx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aldx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aldx Today - Breaking & Trending Today

Analysts Set Expectations for Aldeyra Therapeutics, Inc's Q1 2023 Earnings (NASDAQ:ALDX) - Vimarsana News

Analysts Set Expectations for Aldeyra Therapeutics, Inc's Q1 2023 Earnings (NASDAQ:ALDX)

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) – Oppenheimer issued their Q1 2023 EPS estimates for shares of Aldeyra Therapeutics in a report issued on Thursday, March 9th. Oppenheimer analyst J. Kim expects that the biotechnology company will post earnings of ($0.26) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ current full-year […]

Aldeyra Therapeutics Is a Speculative Stock Worth a Small Position - Vimarsana News

Aldeyra Therapeutics Is a Speculative Stock Worth a Small Position

Seasoned traders who understand risk could nibble on the long side of ALDX....ALDX

Analysts Expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Will Announce Earnings of -$0.32 Per Share - Vimarsana News

Analysts Expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Will Announce Earnings of -$0.32 Per Share

Wall Street analysts expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) to report earnings of ($0.32) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Aldeyra Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.29) and the lowest estimate coming in at ($0.36). Aldeyra Therapeutics […]

Kestra Advisory Services LLC Has $67,000 Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Vimarsana News

Kestra Advisory Services LLC Has $67,000 Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)

Kestra Advisory Services LLC increased its stake in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) by 33.4% during the 4th quarter, Holdings Channel reports. The fund owned 16,809 shares of the biotechnology company’s stock after acquiring an additional 4,212 shares during the period. Kestra Advisory Services LLC’s holdings in Aldeyra Therapeutics were worth […]

Aldeyra Therapeutics (NASDAQ:ALDX) Announces Quarterly Earnings Results - Vimarsana News

Aldeyra Therapeutics (NASDAQ:ALDX) Announces Quarterly Earnings Results

Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) posted its earnings results on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.01, MarketWatch Earnings reports. During the same quarter last year, the firm earned ($0.35) earnings per share. ALDX stock traded up $0.19 during mid-day […]